EADV 2026 Psoriasis Data: Waxing Redefined

EADV 2026: Psoriasis Data for Waxing Specialists

The upcoming European Academy of Dermatology and Venereology (EADV) Congress in 2026 is set to release a wave of new psoriasis research, and for us waxing specialists, it’s going to directly affect how we handle client care. We need to get a handle on these advancements because they will force us to adapt our techniques, especially around clients with this chronic condition. The new data on biologics and skin barrier function coming out of EADV 2026 is going to change our day-to-day best practices for hair removal.

Understanding Psoriasis: A Refresher for Skin Professionals

Psoriasis is a chronic inflammatory condition that affects millions, caused by skin cells growing way too fast, which leads to those familiar thick, red, scaly patches. The cause is a messy combination of genetics, environmental factors, and a misfiring immune system. For us, knowing the different forms of psoriasis is critical because our job involves direct interaction with the client’s skin health. The condition shows up in different ways, like plaque psoriasis (the one we see most often), guttate, inverse, pustular, and erythrodermic psoriasis. Each one brings its own set of challenges to any hands-on skin procedure like waxing. Because psoriasis is inflammatory, the skin barrier is almost always compromised, making it prone to irritation, infection, and the Koebner phenomenon. That’s where simple trauma to the skin, like a wax pull, can actually create a new psoriasis lesion. Get this wrong, and you could make a client’s condition worse and they’ll never trust you again. Knowing these sensitivities helps us make the right call on whether to even perform the service and how to modify our technique if we do.

EADV 2026 Highlights: New Therapies and Their Implications

EADV is where the big dermatology news breaks, and in 2026 we’re expecting major updates on psoriasis treatments. The big story for us will be the new data on biologic therapies. These drugs, like adalimumab, ustekinumab, and secukinumab, work by targeting the specific immune system pathways that drive psoriasis. A report from the European Medicines Agency (EMA) already confirms that these biologics are giving many people with moderate to severe psoriasis huge improvements, sometimes clearing plaques almost completely. For our industry, this is huge. It means a growing number of clients are having long periods of remission, making them perfectly viable candidates for professional waxing when they couldn’t have been before. We’ll also see news on better topical treatments and small molecule inhibitors. While they don’t have the same systemic punch as biologics, the newer topicals are often more effective with fewer side effects than the old-school corticosteroids. Our job is to recognize how these treatments impact the skin’s integrity. A client on a newer topical will likely have skin that’s far less fragile than someone with untreated psoriasis. The EADV 2026 sessions will give us the specific data on how these treatments affect skin barrier resilience, information we can use immediately to make our waxing practices safer.

Adapting Waxing Techniques for Psoriasis-Prone Skin

With the known risk of skin sensitivity and the Koebner phenomenon in psoriasis clients, a customized waxing plan isn’t optional. It all starts with a thorough and empathetic consultation. You need to ask direct questions about their psoriasis: how active is it right now, where are the affected areas, have they had any recent flares, and what’s their current treatment plan? Someone on systemic meds might have more fragile skin, for example. If they have active plaques in the area you’re supposed to wax, you have to say no to the service. This action prioritizes their skin health above all else. When a client’s psoriasis is well-managed and the skin is clear, you can proceed, but with critical adjustments. Use a gentle hard wax that’s designed to grab the hair, not the skin, which helps prevent lifting the epidermis. Don’t even think about using strip wax on a client with a history of psoriasis. Its grip on the skin is too aggressive and poses a much higher risk of trauma. Your technique needs to be flawless: apply the wax in small, manageable sections, hold the skin taut, and pull fast and parallel to the skin. Afterwards, immediately apply a calming, anti-inflammatory product with ingredients like aloe vera, chamomile, or bisabolol. Stay away from anything with fragrance, alcohol, or other harsh irritants. The goal is simple: get the hair with the least possible disruption and the most comfort.

Post-Wax Care and Client Education

The aftercare for a client with psoriasis is where we can prevent serious problems from developing. Giving them clear post-care instructions is our best defense against complications. Tell them to avoid hot baths, saunas, and intense workouts for at least 24 hours, since those activities can increase blood flow and inflammation, and to wear loose-fitting clothes to stop friction on the freshly waxed skin. It’s also our job to educate them on smart at-home care. Suggest they use a gentle, fragrance-free moisturizer every day to keep the skin hydrated and support that fragile barrier. While we normally recommend exfoliation to prevent ingrowns, clients with psoriasis need to be extremely careful. Chemical exfoliants like salicylic or glycolic acid should only be used if their dermatologist gives the green light. Physical scrubs are a definite no-go on any area prone to psoriasis because of the high risk of triggering a Koebner response. Instead, have them focus on hydration and gentle cleansing. When you provide them with good advice and maybe even a link to a resource like a psoriasis patient group, you show you’re a partner in their skin health, not just someone who removes hair. This builds incredible trust.

Future Outlook: Integrating EADV 2026 Insights into Practice

The information coming from EADV 2026 isn’t a one-time update. It’s going to permanently change how we work with psoriasis-prone skin. As new data on treatment effectiveness and skin resilience comes out, the line for who is and isn’t a safe candidate for waxing will move. Staying on top of this research through professional journals and continuing education is just part of the job now. We have to understand the practical side of these medical advancements. For example, if a new biologic is proven to strengthen the skin barrier significantly, it could mean we can finally offer services to clients who have been off-limits for years. On the other hand, if a new treatment is found to thin the skin or cause photosensitivity, we need to build that knowledge into our client intake and consultations immediately. Dermatology is always moving forward, and our practices have to move right along with it. Our goal is to give every single client a safe and comfortable service, and that means knowing exactly what’s happening with their skin, whatever their condition.